Monthly Update12 Feb 2026, 03:37 pm
Vivanza Biosciences Confirms No New Funding via Public Issue or QIP
AI Summary
Vivanza Biosciences Ltd. has confirmed, pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that it has not raised any further funds by means of Public Issue, Rights Issue, or Preferential Issue, etc. The company also stated that it does not need to provide a Statement of deviation(s) or variation(s) as it is not applicable.
Key Highlights
- Vivanza Biosciences confirms no new funding via Public Issue or QIP
- Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 followed
- No deviation or variation statement required as it's not applicable
Price Impact
More from VIVANZA